Soluble interleukin 2 receptor levels and cervical neoplasia: Results from a population-based case-control study in Costa Rica

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 3, 1999, Pages 249-253

  Ung, Anita ^a,b   Kramer, Tim R ^c   Schiffman, Mark ^b   Herrero, Rolando ^d   Bratti, M Concepcion ^d   Burk, Robert D ^e   Swanson, Christine A ^b   Sherman, Mark E ^b,f   Hutchinson, Martha L ^g   Alfaro, Mario ^h   Morales, Jorge ^h   Balmaceda, Ileana ^h   Hildesheim, Allan ^b  

^a Howard Hughes Res Scholars Program   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g TUFTS UNIVERSITY   (United States)

^h CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; COSTA RICA; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CONFIDENCE INTERVALS; COSTA RICA; DISEASE PROGRESSION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORECASTING; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; QUESTIONNAIRES; RECEPTORS, INTERLEUKIN-2; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 6544234525     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pisani, P., Parkin, D. M., Muñoz, N., and Ferlay, J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomark. Prev., 6: 387-400, 1997.
2. Nasiell, K., Roger, V., and Nasiell, M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet. Gynecol., 67: 665-669, 1986.
3. Hildesheim, A., Schiffman, M. H., Gravitt, P., Glass, A. G., Greer, C., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., Kurman, R. J., and Maros, M. M. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon. J. Infect. Dis., 169: 235-240, 1994.
4. Kadish, A. S., Ho, G. Y. F., Burk, R., Wang, Y., Romney, S. L., Ledwidge, R., and Angeletti, R. H. Lymphoproliferative responses to human papillomavirus (HPV) type 16 protein E6 and E7: outcome of HPV infection and associated neoplasia. J. Natl. Cancer Inst., 89: 1285-1293, 1997.
5. Frazer, I. H., and Tindle, R. W. Cell-mediated immunity to papillomaviruses. Papillomavirus Report, 3: 53-58, 1992.
6. Benton, C., Shahidullah, H., and Hunter, J. A. A. Human papillomavirus in the immunosuppressed. Papillomavirus Report 3: 23-26, 1992.
7. Tsukui, T., Hildesheim, A., Schiffman, M. H., Lucci, J., III, Contois, D., Lawler, P., Rush, B. B., Lorincz, A. T., Corrigan, A., Burk, R. D., Qu, W., Marshall, M. A., Mann, D., Carrington, M., Clerici, M. Shearer, G. M., Carbone, D. P , Scott, D. R., Houghten, R. A., and Berzofsky, J. A. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res., 56: 3967-3974, 1996.
8. Clerici, M., Merola, M., Ferrario, E., Trabattoni, D., Villa, M. L., Stefanen, B., Venzon, D. J., Shearer, G. M., DePalo, G., and Clerici, E. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J. Natl. Cancer Inst., 89: 245-250, 1997.
9. Rubin, L. A., and Nelson, D. L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Intern. Med., 113: 619-627, 1990.
10. Hildesheim, A., Schiffman, M. H., Tsukui, T., Swanson, C. A., Lucci, J., III, Scott, D. R., Glass, A. G., Rush, B. B., Lorincz, A. T., Corrigan, A., Burk, R. D., Helgesen, K., Houghten, R. A., Sherman, M. E., Kurman, R. J., Berzofsky, J. A., and Kramer, T. R. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol. Biomark. Prev., 6: 807-813, 1997.
11. Herrero, R., Schiffman, M. H., Bratti, C., Hildesheim, A., Balmaceda, I., Sherman, M. E., Greenberg, M., Cardenas, F., Gomez, V., Helgesen, K., Morales, J., Hutchinson, M., Mango, L., Alfaro, M., Potischman, N. W., Wacholder, S., Swanson, C., and Brinton, L. A. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Pan Am. J. Public Health, 1: 362-374, 1997.
12. Burk, R. D., Ho, G. Y. F., Beardsley, I., Lemps, M., Peters, M., and Bierman, R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J. Infect. Dis., 174: 679-689, 1996.
13. Tollerud, D. J., Clark, J. W., Brown, L. M., Neuland, C. Y., Pankiw-Trost, L. K., Blattner, W. A., and Hoover, R. N. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J. Clin. Immunol., 9: 214-222, 1989.
14. Ben-Hur, H., Mor, G., Insler, V., Blickstein, I., Amir-Zaltzman, Y., Sharp, A., Globerson, A., and Kohen, F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am. J. Reprod. Immunol., 34: 363-369, 1995.
15. deGruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Schiller, J. T., Stukart, M. J., Groot, B. S., Chabaud, M. M. P., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, T. J. M., Meijer, C. J. L. M., and Scheper, R. J. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J. Natl. Cancer Inst., 89: 630-638, 1997.
16. deGruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Stukart, M. J., Robbesom, A. A. J. P., von Blomberg-van der Flier, B. M. E., Herbrink, P., Remmink, A. J., Verheijen, R. H. M., Helmerhorst, T. J. M., Meijer, C. J. L. M., and Scheper, R. J. Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. Int. J. Cancer, 68: 731-738, 1996.
17. Strickler, H. D., Escoffery, C., Rattray, C., Fuchs, D., Wachter, H., Manns, A., Schiffman, M. H., Cranston, B., Hanchard, B., and Blattner, W. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. Cancer Epidemiol. Biomark. Prev., 4: 295-298, 1995.
18. Zerler, B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells (Cold Spring Harbor), 3: 471-479, 1991.